Tuberculin: Clinical Trials

35 trials of Tuberculin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

19 completed, 13 unknown, 1 active not recruiting, 1 not yet recruiting. 10 Not applicable, 9 Phase 2, 9 Phase 4, 4 Phase 3, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable10Completed 4, Unknown 3, Active not recruiting 1, Not yet recruiting 1, Withdrawn 1
Phase 29Completed 6, Unknown 3
Phase 49Completed 5, Unknown 4
Phase 34Completed 2, Unknown 2
Phase 12Completed 2
Early Phase 11Completed 1

Follow Tuberculin: new trials by email Literature Review of Tuberculin trials Research Report on Tuberculin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Posterior Pericapsular Deep-gluteal Block
PENG (Pericapsular nerve group) block, LFCN (Lateral femoral cutaneous nerve) block, PPD (Posterior pericapsular deep gluteal) block - Pain, Postoperative
Not applicableNot yet recruitingAnkara Etlik City Hospital602026-10-202026-10-23
Online Transdiagnostic Group CBT for Postpartum Depression and Anxiety
Cognitive Behavioral Therapy for Postpartum Depression (PPD) and Anxiety - Postpartum Depression (PPD), Postpartum Anxiety
Not applicableActive not recruitingMcMaster University482025-09-092026-01-26
Clinical Study of Recombinant Mycobacterium Tuberculosis Fusion Protein for 65-year-olds and Above
Recombinant Mycobacterium Tuberculosis Fusion Protein, Purified Protein Derivative of Tuberculin - Latent Tuberculosis Infection
Phase 3CompletedAnhui Zhifei Longcom Biologic Pharmacy Co., Ltd.7802023-08-032026-04-30
The Effect of Coenzyme Q10 on Endothelial, Vascular and Myocardial Function
Q10 - Non-Alcoholic Fatty Liver Disease
Phase 2UnknownAttikon Hospital602023-04-012023-07-12
Characterization of Tissue-Specific Immune Responses to Bronchoscopic Instillation of Mycobacterial Antigens Into the Human Lung
Tuberculin Purified Protein Derivative - Healthy, Latent Tuberculosis Infection (LTBI)
Early Phase 1CompletedNational Heart, Lung, and Blood Institute (NHLBI)172022-05-032026-05-27
Impact Of Intralesional Tuberculin Ppd Injection On Anogenital
protein purified derivative - Human Papilloma Virus, Infections
Phase 2CompletedUniversitas Padjadjaran242022-04-012025-07-18
Triple Antigen vs Monoantigen Immunotherapy for Warts
Intralesional antigen immunotherapy - Triple Intralesional Immunotherapy Combination in Multiple Recalcitrant Warts
Phase 2 / Phase 3CompletedZagazig University1602020-11-202022-02-24
Prevalence of Latent Tuberculosis in High Risk Children
Tuberculin, Purified Protein 5Unt/0.1 mL Solution - Latent Tuberculosis
UnknownAssiut University1002020-07-012020-06-16
Efficacy of Cryotherapy Combined With Intralesional Tuberculin PPD Versus Intralesional Tuberculin PPD in Treatment of Multiple Common Warts
Tuberculin purified protein derivative - Common Wart
Phase 3UnknownAssiut University402020-03-012020-02-28
The Efficacy of Intra-lesional Bleomycin Versus Intra-lesional Purified Protein Derivative in Treatment of Palmoplantar Warts
Bleomycin, Purified Protein Derivative - Warts
Phase 4UnknownAssiut University402018-04-012018-03-26
Comparison Between Tuberculin Vaccine and Cryotherapy in Genital Wart Patients
tuberculin, cryotherapy - Genital Wart
Phase 3UnknownAssiut University452017-06-012017-05-17
Pilot-RCT With Individualized Homeopathic Treatment in the Children With Autism Spectrum Disorder
Homoeopathic medicines, Placebo, THERAPY - Autism Spectrum Disorder (ASD)
Phase 4CompletedAditi Chadha542017-01-012025-07-08
Sequential Therapy Versus Quadruple Therapy in H. Pylori Eradication
14-day sequential therapy, Bismuth quadruple therapy - Helicobacter
Phase 4UnknownNational Taiwan University Hospital6202015-09-012017-05-17
Living With Statins - The Impact of Cholesterol Lowering Drugs on Health, Lifestyle and Well-being
Simvastatin, Q10 - Cardiovascular Disease, Diabetes Mellitus
Phase 4CompletedUniversity of Copenhagen352015-01-012017-01-04
The Effect of Coenzyme Q10 on Hearing and Tinnitus Characteristics of Chronic Tinnitus Patients
Q10, placebo - Tinnitus
Not applicableUnknownUniversity Hospital, Antwerp2014-11-012016-04-18
Investigating Immune Mechanisms in Atopic Eczema
Skin biopsy, Skin suction blister, Mantoux test - Atopic Dermatitis
Not applicableWithdrawnUniversity College, London2014-05-012021-04-30
Development of Human Nasal Challenge Models With Microbial Constituents and Grass Pollen
Poly ICLC, Poly I:C, R848 - Allergic Rhinitis, Asthma
Not applicableCompletedImperial College London932014-03-012021-11-05
Phase IIa Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10
1μg/ml ESAT6-CFP10 and tuberculin purified protein derivative, 5μg/ml ESAT6-CFP10 and tuberculin purified protein derivative, 10μg/ml ESAT6-CFP10 and tuberculin purified protein derivative - Tuberculosis
Phase 2CompletedAnhui Zhifei Longcom Biologic Pharmacy Co., Ltd.1442014-02-012015-04-09
Characterisation of T-cell Response to Keyhole Limpet Hemocyanin (KLH) and Tuberculin Purified Protein Derivative (PPD)
KLH 0.1 mg, KLH 5 mg, PBS (0.1 mL) - Dermatitis
Phase 1CompletedGlaxoSmithKline242013-02-222017-05-15
Equivalence Study of Tuberculin Purified Protein Derivative in Comparison With a Reference Standard (PPD-S2)
To compare new PPD to reference standard material, Reference standard - Tuberculosis Identification.
Phase 2UnknownJHP Pharmaceuticals LLC902013-02-012013-02-25

Showing 20 of 35. Sign in to see all of them.

Conditions studied

Tuberculosis (11)  ·  Latent Tuberculosis (7)  ·  Depression, Postpartum (3)  ·  Warts (3)  ·  HIV Infections (2)  ·  Hypersensitivity, Delayed (2)  ·  AIDS-Related Complex (1)  ·  AIDS-Related Opportunistic Infections (1)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Agnosia (1)  ·  Arthritis, Rheumatoid (1)  ·  Asthma (1)  ·  Autism Spectrum Disorder (1)  ·  Bites and Stings (1)  ·  Cardiovascular Diseases (1)

Sponsors

Assiut University (4)  ·  Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. (2)  ·  JHP Pharmaceuticals LLC (2)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (2)  ·  Statens Serum Institut (2)  ·  ASST Fatebenefratelli Sacco (1)  ·  Aditi Chadha (1)  ·  Ankara Etlik City Hospital (1)  ·  Attikon Hospital (1)  ·  GlaxoSmithKline (1)  ·  Hartford Hospital (1)  ·  Imperial College London (1)  ·  Johns Hopkins University (1)  ·  McMaster University (1)  ·  National Heart, Lung, and Blood Institute (NHLBI) (1)

Countries

United States (7)  ·  United Kingdom (4)  ·  Canada (2)  ·  China (2)  ·  Australia (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Denmark (1)  ·  Egypt (1)  ·  Greece (1)  ·  India (1)  ·  Indonesia (1)  ·  Israel (1)  ·  Italy (1)  ·  Nepal (1)

Top investigators

Birgit Thierry-Carstensen (2)  ·  Betina Durovni, M.D. (1)  ·  Brian G. Danaher, PhD (1)  ·  Catherine E Monk, Ph.D. (1)  ·  David JM Lewis, MD (1)  ·  Deepali Kumar, MD (1)  ·  Fatma Ozkan Sipahioglu, MD (1)  ·  Flemming Dela, MD, MDSci (1)  ·  Gordin F (1)  ·  Jeannette Milgrom, PhD (1)  ·  Keertan Dheda, MD (1)  ·  Kevin P Fennelly, M.D. (1)  ·  Malcolm Rustin, MBBS MRCP MD (1)

Results publications

PMID 11238198, PMID 12807939, PMID 15897380, PMID 16973081, PMID 22626835, PMID 23336207, PMID 23691171, PMID 23954450, PMID 24191345, PMID 24874401, PMID 25273231, PMID 25545331, PMID 26677940, PMID 27367855, PMID 27993387, PMID 29641571, PMID 29846605, PMID 30299473, PMID 30923464, PMID 31575091, PMID 32417634, PMID 35159318, PMID 35381849, PMID 36705474, PMID 37146219, PMID 38714999, PMID 38987784

NIH funding

2004 (1), 2009 (1), R01MH084931 (1)